Spots Global Cancer Trial Database for digestive system neoplasms
Every month we try and update this database with for digestive system neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) | NCT03099031 | Venous Thromboe... | Tinzaparin | 18 Years - | LEO Pharma | |
| Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE) | NCT05646511 | Locally Advance... | SCRT CAPOX CAPOXIRI | 18 Years - | National Cancer Center Hospital East | |
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis | NCT00808743 | Familial Adenom... Duodenal Neopla... Duodenal Polyps | Celecoxib Ursodeoxycholic... Placebo | 18 Years - 70 Years | Radboud University Medical Center | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients | NCT01786122 | Non-Small-Cell ... Digestive Syste... Breast Neoplasm... | Supervised Phys... education progr... | 18 Years - 70 Years | Basque Health Service | |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | NCT02993731 | Carcinoma, Panc... | Napabucasin Nab-paclitaxel Gemcitabine | 18 Years - | Sumitomo Pharma America, Inc. | |
| Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | NCT01819766 | Inflammatory Bo... Primary Scleros... Colorectal Neop... Colorectal Canc... | 18 Years - 84 Years | Exact Sciences Corporation | ||
| Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies | NCT01260168 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 40 Years - 90 Years | Exact Sciences Corporation | ||
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | NCT01832116 | Ovarian Neoplas... Ovarian Disease... Adnexal Disease... Pancreatic Neop... Digestive Syste... Digestive Syste... Pancreatic Dise... | 89Zr-MMOT0530A | 18 Years - | University Medical Center Groningen | |
| Celiac Plexus Radiosurgery for Pain Management | NCT02356406 | Digestive Syste... | Celiac Plexus R... | 18 Years - | Sheba Medical Center | |
| Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer | NCT01397747 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 50 Years - 84 Years | Exact Sciences Corporation | ||
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. | NCT02241499 | Adenocarcinoma ... | Radiation thera... Oxaliplatin and... | 18 Years - | Lund University Hospital | |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial | NCT01995942 | Adenocarcinoma Rectal Diseases Colorectal Neop... Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer | NCT02202928 | Colorectal Canc... Neoplasms Intestinal Neop... Digestive Syste... Gastrointestina... | DC-CIK Radiotherapy Chemotherapy | 18 Years - 80 Years | Shenzhen Hornetcorn Bio-technology Company, LTD | |
| Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. | NCT05624099 | Esophageal Neop... Esophageal Dise... Digestive Syste... | camrelizumab Paclitaxel drug... Platinum drug Radiation | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial. | NCT02246725 | Tumor in Upper ... | Contact with pa... | 18 Years - | Lund University Hospital | |
| An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer | NCT01397305 | Rectal Cancer | [6R] 5,10-methy... Pemetrexed | 18 Years - | Isofol Medical AB | |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | NCT01009593 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... Liver Diseases Neoplasms by Hi... Digestive Syste... Carcinoma Liver Neoplasms Neoplasms Neoplasms by Si... Digestive Syste... Adenocarcinoma Neoplasms, Glan... | ABT-869 Sorafenib | 18 Years - | Abbott | |
| Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer | NCT04163900 | Biliary Tract C... | NUC-1031 Gemcitabine Cisplatin | 18 Years - | NuCana plc | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms | NCT05287165 | Advanced Solid ... Digestive Syste... Pancreatic Canc... Colorectal (Col... | IM96 CAR-T cell... | 18 Years - 75 Years | Beijing Immunochina Medical Science & Technology Co., Ltd. | |
| Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas | NCT01088815 | Metastatic Panc... | Gemcitabine, na... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) | NCT02112656 | Hepatocellular ... | ThermoDox Dummy infusion | 18 Years - | Imunon | |
| Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer | NCT04556344 | Digestive Syste... Thoracic Neopla... | Emotional skill... Short free talk... | 18 Years - | University Hospital, Lille | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma | NCT02487017 | Hepatocellular ... Neoplasms Digestive Syste... | Transcatheter A... DC-CIK | 18 Years - 80 Years | Shenzhen Hornetcorn Bio-technology Company, LTD | |
| Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients | NCT01786122 | Non-Small-Cell ... Digestive Syste... Breast Neoplasm... | Supervised Phys... education progr... | 18 Years - 70 Years | Basque Health Service | |
| Microbiome Test for the Detection of Colorectal Polyps and Cancer | NCT02141945 | Colorectal Neop... Colorectal Canc... | 45 Years - 80 Years | Metabiomics Corp | ||
| A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis | NCT06096779 | Hepatocellular ... | Atezolizumab Bevacizumab | 18 Years - | Genentech, Inc. | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Low Rectal Cancer Study (MERCURY II) | NCT02005965 | Adenocarcinoma Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... Rectal Diseases | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients | NCT03117348 | Enteral Nutriti... Postoperative P... Digestive Syste... | Enteral nutriti... | 18 Years - 80 Years | Jinling Hospital, China | |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) | NCT00867113 | Gastrointestina... | imatinib mesyla... | 18 Years - | Novartis | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities | NCT03072472 | Colorectal Neop... Colonic Polyp Adenoma Neoplasia GI Digestive Syste... Intestinal Neop... Neoplasms, Glan... Digestive Disea... Intestinal Dise... Colonic Disease... Rectal Diseases Intestinal Poly... Polyps Pathological Co... | Endocuff Vision | 55 Years - 61 Years | South Tyneside and Sunderland NHS Foundation Trust | |
| Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers | NCT02503631 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | Stool Sample Co... | 40 Years - 90 Years | Exact Sciences Corporation | |
| Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis | NCT00808743 | Familial Adenom... Duodenal Neopla... Duodenal Polyps | Celecoxib Ursodeoxycholic... Placebo | 18 Years - 70 Years | Radboud University Medical Center | |
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | NCT02909452 | Neoplasms Neoplasms, Glan... Neoplasms by Hi... Bronchial Neopl... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Digestive Syste... Endocrine Gland... Carcinoma, Non-... Lung Diseases Breast Diseases Renal Neoplasm Solid Tumors | Entinostat Pembrolizumab | 18 Years - | Syndax Pharmaceuticals | |
| Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma | NCT05913661 | Carcinoma Intrahepatic Ch... Digestive Syste... PD-1 Inhibitor First-line Trea... | Pemigatinib PD-1 Inhibitors | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | NCT01009593 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... Liver Diseases Neoplasms by Hi... Digestive Syste... Carcinoma Liver Neoplasms Neoplasms Neoplasms by Si... Digestive Syste... Adenocarcinoma Neoplasms, Glan... | ABT-869 Sorafenib | 18 Years - | Abbott | |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms | NCT06026800 | Digestive Syste... | iNeo-Vac-R01 | 18 Years - 75 Years | Sir Run Run Shaw Hospital | |
| A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms | NCT04755543 | Digestive Syste... | LP002 Cisplatin Fluorouracil OH2 oncolytic v... | 18 Years - 75 Years | Taizhou HoudeAoke Biomedical Co., Ltd. | |
| Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | NCT04080843 | Colorectal Canc... RAS and BRAF Wi... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Rectal Diseases | Anlotinib Hydro... Capecitabine Oxaliplatin | 18 Years - 75 Years | Zhejiang University | |
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | NCT04962958 | Carcinoma Carcinoma, Hepa... Liver Neoplasms Digestive Syste... Antineoplastic ... Donafenib Fluorouracil Oxaliplatin Antimetabolites | Hepatic arteria... Folfox Protocol Donafenib | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy | NCT04640792 | Screening Colon... Surveillance Co... | Screening or Su... | 18 Years - 90 Years | Magentiq Eye LTD | |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | NCT01294826 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... Adenocarcinoma ... Adenocarcinoma ... | AUY922 Cetuximab | 18 Years - | Swedish Medical Center | |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors | NCT01177007 | Liver Neoplasms | TheraSphere, Yt... | 18 Years - | Yale University | |
| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | NCT05252078 | Esophageal Squa... Esophageal Neop... Esophageal Dise... Gastrointestina... Gastrointestina... Digestive Syste... Digestive Syste... Neoplasms by Si... Neoplasms by Hi... Neoplasms, Squa... Carcinoma, Squa... | Anlotinib hydro... TQB2450 | 18 Years - | Jiangxi Provincial Cancer Hospital | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma | NCT05913661 | Carcinoma Intrahepatic Ch... Digestive Syste... PD-1 Inhibitor First-line Trea... | Pemigatinib PD-1 Inhibitors | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer | NCT00838578 | Colorectal Canc... | KRN330 Irinotecan | 18 Years - | Kyowa Kirin Co., Ltd. | |
| EUS-guided RFA for Solid Abdominal Neoplasms | NCT03221335 | Digestive Syste... | EUS-guided RFA | 18 Years - | Chinese University of Hong Kong | |
| EUS-guided RFA for Solid Abdominal Neoplasms | NCT03221335 | Digestive Syste... | EUS-guided RFA | 18 Years - | Chinese University of Hong Kong | |
| A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib | NCT03008512 | Carcinoma, Hepa... | Genexol-PM | 20 Years - | Gachon University Gil Medical Center | |
| TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA. | NCT05233098 | Hepatocellular ... | Technetium-99m ... | 21 Years - | Boston Scientific Corporation | |
| TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA. | NCT05233098 | Hepatocellular ... | Technetium-99m ... | 21 Years - | Boston Scientific Corporation | |
| The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | NCT03889626 | Stomach Neoplas... Gastrointestina... Stomach Disease... Digestive Syste... Capecitabine Apatinib Neoplasms Molecular Mecha... | Apatinib Capecitabine | 18 Years - 90 Years | Fudan University | |
| Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients | NCT01786122 | Non-Small-Cell ... Digestive Syste... Breast Neoplasm... | Supervised Phys... education progr... | 18 Years - 70 Years | Basque Health Service | |
| Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients | NCT03115957 | Digestive Syste... | Parenteral Nutr... | 18 Years - 80 Years | Jinling Hospital, China | |
| Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) | NCT03488446 | Digestive Syste... Gastrointestina... Digestive Syste... Gastrointestina... Stomach Neoplas... | 18 Years - | Nanfang Hospital, Southern Medical University | ||
| Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | NCT01550510 | Stage IV Colore... | Ascorbic Acid Irinotecan | 18 Years - | Thomas Jefferson University | |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | NCT02897778 | Neoplasms Neoplasms, Glan... Neoplasms by Hi... Bronchial Neopl... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Digestive Syste... Endocrine Gland... Carcinoma, Non-... Lung Diseases Breast Neoplasm... Breast Diseases Renal Neoplasm Solid Tumors | Entinostat Placebo | 18 Years - | Syndax Pharmaceuticals | |
| Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | NCT02215837 | Gastric Cancer Neoplasms Gastrointestina... Digestive Syste... Gastrointestina... | Chemotherapy Ag-D-CIK | 18 Years - 80 Years | Shenzhen Hornetcorn Bio-technology Company, LTD |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
